In this study 4 patients were post-kala-azar dermal leishmaniasis (PKDL), whose lesions were similar to those of lepromatous and borderline leprosy, are described. In 2 patients there was no previous history ofkala-azar but they were residents of an area of known endemic kala-azar. Lack of proper clinical and laboratory assessment was behind the fa ilure to diagnose PKDL. Conse quently the patients were treated with anti leprosy drugs without proof of leprosy. The 3rd and 4th patients, though suspected clinically of leprosy, were correctly diagnosed as PKDL with adequate history, clinical assessment and appropriate laboratory investigations.
Post-kala-azar dermal leishmaniasis (PKDL) is characterized by the development of macules, papules, nodules or infiltrative plaques in the skin, usually fo llowing treated kala-azar. In some patients there is no past history of kala-azar.I, 2 The condition is most frequent in India where it develops 1-5 years after the apparent cure of kala-azar. 3,4 PKDL also occurs in the Sudan 2 ,5 and Kenya.6 Unlike the Indian fo rm, African PKDL is less frequent and develops during or shortly after treatment of Kala-azar. 6 Clinically the nodules and hypopigmented macules may be confused with leprosy, as may the pathology, particularly when the recently-described neuritis of the cutaneous nerves is present in the PKDL lesion? or when there is an epithelioid granuloma in which the parasites cannot be fo und.
In this paper we describe patients with PKDL who were misdiagnosed or who could have been misdiagnosed as leprosy sufferers because their symptoms strikingly resembled various fo rms of leprosy. Distinguishing fe atures between PKDL and leprosy are described.
Case reports
The first patient was an Ethiopian refugee who reported with 2-year-old skin lesions on the fa ce. At the onset of his illness, 5 years before, he had been diagnosed elsewhere as having leprosy on clinical grounds and was treated for I year with dapsone and rifampicin without improvement.
A skin biopsy was then performed. It showed a mononuclear cell infiltrate consisting of lymphocytes, plasma cells and macrophages. No leishmania parasites were fo und but the pathology was considered to be suggestive of leishmaniasis.
The patient was consequently treated with sodium stibogluconate (Pentostam, Wellcome Laboratories, U.K.) for 2 months. The lesions disappeared but recurred I year later and have persisted ever since. On physical examination the only abnormality was fo und in fa cial skin. This showed nodules and infiltrative plaques over the chin, the left cheek, the nose and the eyebrows.
Peripheral nerves were normal and sensations were intact. A slit smear was negative for leishmania and acid-fast bacilli. A biopsy showed a chronic inflammatory reaction consisting of lymphocytes, plasma cells and macrophages. No leishmania parasites were detected. The patient was treated with Pentostam at a dose of 20 mg/kg daily for 3 months. Allopurinol at a dose of 20 mg/kg per day was also given at the same time. The lesions completely subsided and the patient remained welI at 3 months fo lIow up.
The second patient was a 24-year-old male from a known area of endemic kala-azar in the Sudan. He reported with a 10-year history of a skin rash involving the fa ce, trunk, neck and limbs. He had no history of kala-azar. The patient had been on anti leprosy treatment in another hospital for the previous 5 years without improvement.
The lesions were maculopapular and symmetrical. In some areas, particularly over the fa ce, some of the lesions were annular with a coppery depigmented macule in the centre and papules at the margins ( Figure I ). Peripheral nerves were normal and skin sensations were intact. A slit smear showed leishmania parasites and there were no acid-fast bacilIi. A direct agglutination test fo r serum antibodies against leishmania (DAT) was positive. 8 The patient was treated with IV Pentostam at a dose of 20 mg/kg daily for 30 days. The lesions healed completely and he remained welI for 1 year, when he reported with a recurrence.
He was then treated with Pentostam and AlIopurinol at the same dosage and for the same duration as the I st patient. His lesions cleared and he remained well at the 14-month fo llow-up.
The 3rd patient was a 20-year-old male who had kala-azar 5 years before reporting to us. He developed skin lesions on the face, ears, neck, upper limbs and trunk I month after treatment of the kala-azar. He was seen by a dermatologist, who made a provisional diagnosis of lepromatous leprosy. A biopsy, however, was diagnosed as tuberculoid leprosy by a pathologist.
Because of the discrepancy between the clinical and the pathological diagnosis the patient was referred for evaluation. Examination revealed symmetrical nodular lesions and plaques involving the skin of the extremities, fa ce, neck and trunk (Figure 2) . There was a marked lobulation of the ears. Peripheral nerves, motor power and reflexes were normal. Skin sensations were intact. A slit smear showed leishmania parasites. No acid-fast bacilli were fo und. A skin biopsy showed discrete epithelioid granulomas, lymphocytes and plasma cells. DAT was positive. The patient was treated with IV Pentostam at 20 mg/kg daily for 30 days. His lesions regressed markedly. After 6 months he was readmitted with a recurrence of lesions. He was treated with Pentostam and allopurinol, as described above. His lesions regressed but he was left with scars on the neck.
The 4th patient was discovered during a survey for kala-azar in a small village in the Eastern Sudan, near the border with Ethiopia. He was a 12-year-old male who had been treated for kala-azar when 8 years old. He developed a skin rash 10 days after the kala azar treatment. He received no fu rther treatment and the lesions gradually became worse. Examination showed macular and papular lesions on the face, upper limbs, neck and trunk. The lesions on the face and back were macules with a coppery appearance, and were symmetrical.
Over the chest and abdomen the depigmented areas were large and confluent ( Figure  3 ). Over the shoulders and neck the lesions were maculopapular. Peripheral nerves and skin sensations were normal. DA T was positive . A slit smear showed leishmania parasites and there were no acid-fast bacilli. The patient was treated by a medical assistant in the village with Pentostam at a dose of IO mg/kg daily for 15 days.
At fo llow-up I year later the lesions had improved markedly but the hypopigmen tation did not disappear completely. Because the treatment given was considered inadequate the patient was given another course of Pentostam of 10 mgjkgjday for 30 days but was not seen again.
Discussion
The first 2 patients were misdiagnosed as having leprosy and received antileprosy treatment, without benefit. A possible reason why PKDL was not initially considered in the differential diagnosis was because the patients did not give a previous history of kala azar. In the Sudan most cases of PKDL fo llow an attack of kala-azar but it may occasionally occur in the absence of a history of a clinically manifest kala-azar. 1 The I st patient was clinically diagnosed as lepromatous leprosy. Apart from the nodular lesions there were no other fe atures ofJeprosy. A properly performed skin smear, which is always positive in lepromatous leprosy, would have been negative in this patient and therefore would have excluded that diagnosis. The original diagnosis was made in a refugee camp by an expatriate physician who perhaps had little experience of the endemic diseases of the area.
It was only after the patient failed to respond to antileprosy treatment that the possibility of leishmaniasis was entertained. Leishmania parasites were neither fo und in the 1st biopsy nor in the one performed in our hospital. This is not surprising since parasites are sometimes few in number and cannot be identified in the section.9 In such cases culture, animal inoculation, or a polymerase chain reaction with appropriate primers may be helpful.
Clinically in this patient, diffuse cutaneous leishmaniasis, which occurs in Ethiopia, is an important differential diagnosis. Pathologically, however, this can be ruled out as leishmania parasites are numerous in diffuse cutaneous leishmansis and lymphocytes are scanty.IO These fe atures were absent in the present case.
The second patient simulated borderline leprosy. In the latter condition there may be a few or several asymmetrical hypopigmented erythematous or coppery, partly well defined patches. I I Annular and punched out lesions are characteristic. Our patient had annular lesions, papules and coppery macules. The lesions were possibly too symmetrical for borderline leprosy. A slit smear, which is usually positive for Mycobacterium leprae in borderline leprosy, was not done when the initial diagnosis was made, and biopsy was not performed. The patient was referred fo r evaluation only when the anti leprosy treatment had fa iled to improve or clear the lesions. Eventually a slit smear and biopsy showed leishmania parasites and the patient responded to antileishmanial therapy.
The clinical appearance of the 3rd patient was remarkably similar to lepromatous leprosy. The lesions were symmetrical nodules and plaques. However, other fe atures of long-standing lepromatous leprosy, such as madarosis, nasal involvement, thickened nerves, trophic ulcers and impairment of sweating were lacking. The diagnosis of lepromatous leprosy was dismissed when the pathology showed epithelioid granulomas and no mycobacteria. The diagnosis of PKDL was made on the demonstration of leishmania parasites in smears and the past history of kala-azar.
The 4th patient could easily have been mistaken for borderline leprosy. Indeed, when his photographs were shown to a group of dermatologists with experience in leprosy, most fa voured a clinical diagnosis of borderline leprosy. The demonstration ofleishmania parasites, the previous history of kala-azar, the positive serology and the marked improvement fo llowing antileishmanial therapy proved the leishmanial aetiology of the disease.
In 3 of the patients in whom serology was done, antibodies against leishmania were fo und-El Hassan et al. have already demonstrated that such antibodies are not fo und in the various fo rms of leprosy.l
